📰 Second Generation Antipsychotics News
Second Generation Antipsychotics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Second Generation Antipsychotics. Real-time updates on events, politics, business and more.
February 2, 2024
Recent research highlighted the potential role of an atypical antipsychotic to treat anxiety — a prevalent and undertreated symptom in BPD that comes without the typical metabolic side effects.
February 1, 2024
Iloperidone, an atypical antipsychotic approved for schizophrenia, appears to be safe and effective in the treatment of bipolar mania, phase 3 results of an RCT showed.
January 4, 2024
Higher doses of a second-generation antipsychotic are associated with an increased risk of dying in young adults aged 18-24 years, results of a large retrospective cohort study showed.
January 25, 2023
/PRNewswire/ -- The "Post-traumatic Stress Disorder Treatment Market, by Drug Class, by Route of Administration, by Age Group, by Distribution Channel and by...
September 14, 2022
The researchers find that the drug effects for reducing psychosis are small and that treatment failure and severe side effects are common
December 11, 2021
Psychiatry has long turned a blind eye to the full scope of harm associated with TD. New TD drugs "work" by further impairing brain function.
December 10, 2021
Children, teens, and adults can get bipolar disorder 2021. However, the condition is manageable with proper treatment and a healthy lifestyle.
December 10, 2021
Children, teens, and adults can get bipolar disorder 2021. However, the condition is manageable with proper treatment and a healthy lifestyle.
May 25, 2021
: The rising prevalence of urea cycle disorders is expected to increase the demand for treatment options for urea cycle disorders (UCD), which is expected to drive the growth of global urea cycle disorders treatment market during the forecast period. According to the Urea Cycle Disorders Consortium (UCDC), a part of the Rare Diseases Clinical Research Network (RDCRN), combined prevalence of urea cycle disorders is around 1 in 30,000 people in the U.S in 2017 Among regions, North America is exp...